BIOTECHNOLOGY
Statistics
Aggregated valuation multiples, financial performance, and profitability metrics across companies within this industry — with maximum, average, and minimum values for precise peer benchmarking.
All financial metrics are internally calculated based on companies tracked in our database and may not reflect complete market data or official filings. This content is provided for informational purposes only and should not be considered investment advice.
Valuation & Market Metrics
Maximum
Average
Minimum
Market Capitalization
133,368,603,000
2,545,866,133
156,720
EV to revenue ratio (TTM)
400,346.36
2,755.877
0.001
EV to ebitda
1,405.48
11.269
-327.19
Financial Performance
Maximum
Average
Minimum
Revenue (TTM)
15,534,700,000
232,166,923
-3,595,000
Gross profit (TTM)
6,917,600,000
108,975,748
-1,471,000,064
EBITDA
5,100,500,000
-46,905,772
-2,195,000,064
Profitability
Maximum
Average
Minimum
Operating margin (TTM)
352,965.00%
-8,881.41%
-1,183,425.00%
Profit margin
7,051.00%
-5.01%
-289.40%
Return on assets (TTM)
48.80%
-38.43%
-399.30%
Return on equity (TTM)
173.70%
-353.85%
-35,523.00%
Per Share Metrics
Maximum
Average
Minimum
Revenue per share (TTM)
1,240.63
5.084
-0.02
EPS
2,060.7
1.691
-2,793.29
Diluted EPS (TTM)
2,060.7
1.691
-2,793.29
Book value
316.11
5.628
-36.43
Dividend per share
3.64
0.812
0
Dividend yield
1.56%
0.41%
0.00%
Valuation Multiples
Maximum
Average
Minimum
P/E ratio
258
26.356
0
Trailing P/E
258
27.109
0
Forward P/E
3,333.33
65.041
0.178
PEG ratio
159.25
3.109
-2.5
Price to sales ratio (TTM)
478,368.5
2,877.495
0.079
Price to book ratio (TTM)
2,569.66
29.112
0.006
Growth
Maximum
Average
Minimum
Quarterly earnings growth (YoY)
37,272.00%
349.09%
-100.00%
Quarterly revenue growth (YoY)
2,664.00%
18.65%
-97.20%
Analyst Sentiment
Maximum
Average
Minimum
Strong buy
9
1
0
Buy
19
5
0
Hold
17
1
0
Sell
3
0
0
Strong sell
2
0
0
Risk & Volatility
Maximum
Average
Minimum
Beta
4.828
1.046
-4.309